After the dosing amendment, this incidence was 3% 3108. Controlled trials comparing intravenous iv to oral melphalan. Find patient medical information for melphalan oral on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Feb 01, 2020 melphalan is the active lisomer of the compound and was first synthesized in 1953 by bergel and stock. A catalogue record for this book is available from the british library. Renal pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function. Melphalan is in a class of medications called alkylating agents. Dosing guidelines for varying degrees of renal impairment are stated accordingly. Melphalan powder for solution for injection 50mg drug. Renal impairment crcl mlmin melphalan dose 50 100% 3050 2reduce dose to 140mgm dosing in obesity defined as body mass index 30kgm2 consider dosing patients using actual body weight. Alkeran for injection melphalan hydrochloride dose. Melphalan injection should be given only under the supervision of a doctor with experience in the use of chemotherapy medications.
Dosing guidelines book school of medicine university of louisville. Patients with renal impairment are treated on protocol b. Dosing guidelines book dosing guidelines for children dosing guidelines for adults. Pediatric drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in psychiatry. Meaning, your ability to conceive or father a child may be affected by melphalan. Pharmacokinetic, summary of product characteristics spc, relevant pharmaceutical company data and various references have been. Renal failure patients tend to have a low serum albumin, which may affect mel pharmacokinetics, as 60% of the drug is bound to plasma proteins, primarily albumin. Melphalan may cause fertility problems or dangerous allergic reactions in some people. Melphalan is used to treat multiple myeloma a type of blood cancer and cancer of the ovary. Population pharmacokinetics of melphalan in patients with. Renal impairment crcl mlmin melphalan dose 50 100% 3050 2reduce dose to 140mgm dose may be split over 2 days hepatic impairment there are no dose recommendations for melphalan in hepatic impairment.
This study was registered with the australian clinical trials registry registration number. Dosing guidelines book school of medicine university of. Melphalan 200 mgm2 in patients with renal impairment is. Find medication information including related drug classes, side effects, patient statistics and answers to frequently asked questions. What is the recommended melphalan dosage for ovarian cancer. Acute renal insufficiency after highdose melphalan in patients with primary systemic amyloidosis during stem cell transplantation nelson leung, jeff m. Melphalan is used to treat multiple myeloma a type of cancer of the bone marrow. Before the dosing amendment, there was a 10% 877 incidence of drugrelated death in the iv arm. Dosing in obesity defined as body mass index 30kgm2 consider dosing patients using actual body weight.
This book is distributed under the terms of the creative commons. Acute and chronic renal failure are the two kinds of kidney failure. Because clinical trials are conducted under very specific conditions, the adverse event. Consult local institutional guidelines for alternate dosing options. We evaluated the impact of ri on outcomes of patients with multiple myeloma treated with melphalan 200 mgm2 mel200 and autologous stem cell transplantation. Abacavir abacavir lamivudine abacavir lamivudine zidovudine acarbose acebutolol acetaminophen acetazolamide acetohexamide acetohydroxamic acid acetylsalicylic acid aspirin acrivastine acyclovir adefovir adenosine albuterol inhaled albuterol oral alfentanil alfentanil allopurinol alprazolam alteplase tissuetype plasminogen activator. Patients with adpkd and renal impairment, ckd stage g3b and beyond. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020, wolters kluwer updated.
Find information about common, infrequent and rare side effects of melphalan intravenous. Renal pharmacotherapy is a comprehensive and evidencebased listing of dosage recommendations for patients with compromised renal function this uptodate guide closes several identified knowledge gaps concerning medications eliminated by the kidneys. Renal dose adjustmentsin patients with moderate to severe renal impairment, currently available pharmacokinetic data do not justify an absolute recommendation on dosage reduction to those patients, but it may be prudent to use a reduced dose initially. Preassessment ensure pretransplant workup investigation form b.
What is the recommended alkeran dosage for multiple myeloma. Chronic kidney disease ckd is defined as the presence of kidney damage or. Melphalan fda prescribing information, side effects and uses. The renal drug handbook the st georges hospital, adult critical. Highdose melphalan and stem cell transplantation hdmsct is valuable in selected patients with immunoglobulin lightchain amyloidosis and monoclonal immunoglobulin deposition diseaseassociated endstage renal disease.
Melphalan is also used to treat a certain type of ovarian cancer cancer that begins in the female reproductive organs where eggs are formed. Melphalan side effects, dosage, interactions drugs. Common and rare side effects for melphalan intravenous. Uclh dosage adjustment for cytotoxics in renal impairment version 3 updated january2009 page 2 of 24 dosage adjustment for cytotoxics in renal impairment this table is a guide only. Searches for information contained in the primary literature were per. This uptodate and evidencebased reference closes several identified knowledge gaps concerning medications eliminated by the kidneys. Plerixafor is used in people with nonhodgkins lymphoma or multiple myeloma. Melphalan can cause a severe decrease in the number of blood cells in your bone marrow.
We concluded that bsa dosing of melphalan results in wide variations in the mgkg dose, and that patients with renal dysfunction who are scheduled to receive a high mgkg melphalan dose have the. This was most often necessary for dose adjustment of medications used for patients receiving renal replacement therapy. For renally excreted drugs with a narrow therapeutic index, the total daily maintenance dose may be reduced either by decreasing the dose or by increasing the dosing interval, or sometimes by a combination of both. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. This may cause certain symptoms and may increase the risk that you will develop a serious infection or bleeding. The 5year overall survival was 54% and associated with achievement of complete hematologic response after hdmsct. Mar 19, 2020 melphalan by injection melphalan melfalan treats multiple myeloma. The information on dosage adjustments in renal impairment given in this book is based on cockcroftgault creatinine clearance and not egfr, since the majority. Plerixafor helps your bone marrow release stem cells into your bloodstream so they can be collected and transplanted back into your body.
This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Patients on dialysis who received mel were dialyzed before mel infusions and again 2448 h after stem cell infusion. Severe bone marrow suppression with resulting infection or bleeding may occur. This book consists of a brief introductory chapter con taining a discussion of drug ther apy in patients with renal. Melphalan powder for solution for injection 50mg drug medication dosage information. This dose is repeated every four to five weeks, as long as blood cell counts are not too low. The term renal failure denotes the inability of the kidneys to perform excretory function. Renal pharmacotherapy dosage adjustment of medications. Melphalan should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Melphalan powder for solution for injection drug information. Melphalan powder for solution for injection drug summary. Your healthcare provider will recommend an amount and schedule that works best for your particular situation. The table includes adverse events that presented during drug treatment but may not necessarily have a causal relationship with the drug.
Nov 09, 2018 melphalan is a cancer medication that interferes with the growth and spread of cancer cells in the body. There is no general agreement that all the procedures recommended in the guidelines are necessary or appropriate. The psychological impact of hemodialysis on patients with chronic. Alkeran, evomela, melphalan hydrochloride novaplus, premierpro rx melphalan hcl there may be other brand names for this medicine. Highdose melphalan and stem cell transplantation in patients. Acute renal insufficiency after highdose melphalan in. Oct 22, 2009 this study was a prospective, multicentre, observational investigation of the pharmacokinetics of melphalan in patients who underwent asct as part of their treatment for multiple myeloma. Plerixafor may also be used for purposes not listed in. This compares to an overall 1% 1100 incidence of drugrelated death in the oral arm. Seyffarts directory of drug dosage in kidney disease. Sep 04, 2019 where can i get more information mozobil. Data on the effectiveness and toxicity of highdose melphalan in patients with renal impairment ri are lacking. Blinatumomab nearly doubles survival time in bcell all. Dosage adjustment for cytotoxics in renal impairment.
Melphalan 458 mepacrine hydrochloride unlicensed product 460 meptazinol 461 mercaptopurine 462. The usual recommended dose of melphalan tablets for the treatment of cancer of the ovaries is 0. Blinatumomab is the first of a novel class of drugs known as bispecific tcell engagers bite and is designed to direct cytotoxic tcells to cd19expressing cancer cells. Diarrhea mild with regular dosing, can be severe with highdose therapy. There are several dosing regimens that can be used to treat multiple myeloma. Jan 23, 2020 in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. The dose of alkeran can vary significantly from person to person. Learn about the reported side effects, related class drugs, and how these medications will affect your daily lifestyle. Initially 610 mg daily for 57 days, then reduced to 24 mg daily until satisfactory response, then reduced to 26 mg once weekly. This medicine is used to treat multiple myeloma and ovarian cancer.
245 149 151 1184 1328 197 61 243 172 1436 197 714 1163 224 1468 531 959 1406 11 1482 154 698 893 659 1386 736 86 942 23 929 379 470 309 53 555 341 467 172 60